ALDH18A1 and metabolic dysfunction-associated steatotic liver disease: To fill this research gap, we evaluated the diagnostic performance of GPR for significant fibrosis, severe fibrosis, and cirrhosis in one hundred and thirty-one CHB-NAFLD patients, and compared with APRI and FIB-4 scores.